Chronic renal failure: Oxidative stress, endothelial dysfunction and wine

Clinical Nephrology

Volumn 62, Issue 5, 2004, Pages 331-335

  Caimi, G ^a,b   Carollo, C ^a   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Chronic renal failure; Endothelial function; Oxidative stress; Wine polyphenols

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ENDOTHELIN 1; GUANYLATE CYCLASE; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOL; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ALCOHOL CONSUMPTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG TISSUE LEVEL; ENDOTHELIUM LESION; ENZYME INHIBITION; GRAPE JUICE; HUMAN; NONHUMAN; OXIDATIVE STRESS; RED WINE; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION; WINE;

EID: 8344222956     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp62331     Document Type: Review

References (47)

1. Athyros VG, Papageorgiou AA, Elisaf M, Mikhalidis DP 2003 Statins and renal function in patients with diabetes mellitus. Curr Med Res Opin 19: 615-617
2. Andriambeloson E, Kleschyov AL, Muller B, Beretz A, Stoclet JC, Andriantsitohaina R 1997 Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 120: 1053-1058
3. Annuk M, Zilmer M, Fellstrom B 2003 Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int Suppl 84: S50-53
4. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS 2000 Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo-controlled trial. Lancet 356: 1213-1218
5. Bruder JL, Hsieh TC, Lerea KM, Olson SC, Wu JM 2001 Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biology 2: 1
6. Caimi G, Carollo C, Lo Presti R 2003 Diabetes mellitus and oxidative stress: the protective effect of wine. Curr Med Res Opin 19: 581-586
7. Caimi G, Carollo C, Lo Presti R Wine and endothelial function. Drugs Exp Clin Res, in press
8. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps-Latscha B 1996 Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21: 845-853
9. Ceriello A, Bortolotti N, Motz E, Lizzio S, Russo A, Selmo V, Catone B, Tonutti L, Taboga C 2001 Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest 21: 322-328
10. Chauveau P Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, Jungers P 1993 Hyperhomocystinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43: S72-77
11. Cheng TO 2002 Is dealcoholized red wine the final solution? The Japanese paradox. Am J Cardiol 89: 1150
12. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu dos Santos AC, Wood EG, Carrier MJ 2001 Endothelin-1 synthesis reduced by red wine. Nature 414: 863-864
13. Eizawa T, Murakami Y, Matsui K, Takahashi M, Muroi K, Morimasa A, Takano R, Kusano E, Shimada K, Ikeda U 2003 Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 19: 627-633
14. Fitzpatrick DF, Hirschfield SL, Coffey RG 1993 Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265: H774-H778
15. Galle J, Bengen J, Schollmeyer P, Wanner C 1995 Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. Circulation 92: 1582-1589
16. Galle J, Heermeier K, Wanner C 1999 Atherogenic lipoproteins, oxidative stress, and cell death. Kidney Int 56 (Suppl 71): S62-65
17. Galle J, Heinloth A, Wanner C, Heermeier K 2001 Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney Int Suppl 78: S120-123
18. Galle J, Seibold S, Wanner C 2003 Inflammation in uremic patients: what is the link? Kidney Blood Press Res 26: 65-75
19. Galle J, Wanner C 1999 Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation. Miner Electrolyte Metab 25: 263-268
20. Galle J, Wanner C 1997 Oxidative stress and vascular injury - relevant for atherogenesis in uremic patients? Nephrol Dial Transplant 12: 2480-2483
21. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AAE, Panichi V, Filippi C, Bertelli A 2001 Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37:262-270
22. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM 1999 Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21WAF/CIP1, and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 59: 2596-2601
23. Liu Y, Tanaka H, Sasazuki S, Yoshimasu K, Kodama H, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Koyanagi S, Hiyamuta K, Doi Y, Kawano T, Nakagaki O, Takada K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A 2001 Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women. Atherosclerosis 156: 177-183
24. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C 2003 Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18: 1272-1280
25. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D 2000 Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant 15 (Suppl 5): S69-S80
26. Massy ZA, Nguyen-Khoa T 2002 Oxidative stress and chronic renal failure: markers and management. J Nephrol 15: 336-341
27. Miyata T, Wada Y Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C 1997 Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51: 1170-1181
28. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, Imaizumi T 2000 Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation 101: 1002-1006
29. Morena M, Cristol JP, Canaud B 2000 Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif 18: 191-199
30. Neuzil J, Weber C, Kontush A 2001 The role of vitamin E in atherogenesis: linking the chemical, biological and clincial aspects of the disease. Atherosclerosis 157: 257-283
31. Paniagua R, Frias Y de Ventura MJ, Rodriguez E, Hurtado ME, Alcantara G, Vazquez R, Ortiz R, Salcedo M, Rios ME, Kaji J, Amato D 2003 C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int 23: 132-137
32. Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P 2003 Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41: 1212-1218
33. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Grego F, Pauletto P 2003 New markers of accelerated atherosclerosis in end-stage renal disease. J Nephrol 16: 11-20
34. Renaud S, de Lorgeril M 1992 Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526
35. Rendig SV, Symons JD, Longhurst JC, Amsterdam EA 2001 Effects of red wine, alcohol and quercetin on coronary resistance and conductance arteries. J Cardiovasc Pharmacol 38: 219-227
36. Rodrigo R, Rivera G 2002 Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Rad Biol Med 33: 409-422
37. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J 1999 Effect of red wine on coronary flow-velocity reserve. Lancet 354: 1002
38. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD 1999 Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation inpatients with coronary artery disease. Circulation 100: 1050-1055
39. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T 1999 Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911
40. Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H, Chayama K 2002 Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165: 145-152
41. Vallance P, Leone A, Calver A, Collier J, Moneada S 1992 Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575
42. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72: 2219-2233
43. Wanner C, Zimmermann J, Schwedler S, Metzger T 2002 Inflammation and cardiovascular risk in dialysis patients. Kidney Int 61 (Suppl 80): S99-102
44. Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastelein J, Versluis K, Lagerwerf F, van Rijn H, Koomans H, Rabelink T 1999 Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19: 1168-1172
45. Wollin SD, Jones PJH 2001 Alcohol, red wine and cardiovascular disease. J Nutr 131: 1401-1404
46. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R, CREED Investigators 2002 Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490-496
47. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R 2001 Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113-2117